Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001062993-23-006326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | 2023-03-06 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +118.2K | 492.9K | +32% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +177.4K | 177.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 118,203 | $0.00 | 492,891 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-03-06 | A | A | 177,377 | $0.00 | 177,377 | D | $8.46 · — to 2033-03-06 | 177,377 Common Stock | (F1) The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |